SEC Form 4 · accession 0001255294-15-000032
Rich Pharmaceuticals, Inc. · RCHA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ben Chang
Officer — CEO, CFO, Pres · Director · 10% Owner
Period of report
Jan 12, 2015
Accepted (ET)
Jan 15, 2015 · 1:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504389
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $0.0017 | Oct 6, 2014 | A | 3,240,000 | A | Oct 6, 2014 | Oct 6, 2018 | Common Stock | 3,240,000 | 3,246,000 | D |
Explanation of responses
- F1The Reporting Person was granted options to purchase under the Rich Pharmaceuticals, Inc. 2013 Stock Option/Stock Issuance Plan. The stock options are immediately vested and may be exercised by cashless exercise.
- F2Effective January 12, 2015, the Company approved the re-pricing of all of the 3,000,240 previously granted options under the Company's 2013 Equity Incentive Plan, which had exercise prices between $0.30 per share and $$.0191984 per share, to $0.0017 per share which was the closing price of the Company's common stock on January 9, 2015. All of the other terms of the options remained unchanged.